Pope Leo XIV calls out massacre in Democratic Republic of Congo, highlighting global persecution of Christians in Nigeria, Sudan and other nations.

The Democratic Republic of the Congo and the M23 rebel group have signed a framework peace deal aimed in the at ending fighting in eastern Congo.

The European Commission is providing an additional €9 million in humanitarian assistance for the Democratic Republic of the Congo (DRC) to respond to the tragic humanitarian needs in the country. This pledge comes as the EU's High Representative for Foreign Affairs and Security Policy Kaja Kallas is attending the conference in Paris in support of peace and prosperity in

The Democratic Republic of Congo and the Rwanda-backed M23 militia signed a new peace framework on Saturday in Qatar aimed at ending the fighting that has devastated eastern DRC.

The number of children facing emergency levels of hunger in the Democratic Republic of the Congo (DRC) is expected to surge by at least 20% by the new year due to ongoing violence, displacement and seasonal food shortages, according to Save the Children. [1]

The near-miss comes just two days after a deadly mining accident in the Kalondo region, where 32 people were killed. The ministerial team was travelling to assess the site and meet local officials, making the aviation scare even more concerning for national security and crisis-management officials.

All those on board an Embraer ERJ-145 carrying a government delegation to Kolwezi in the Democratic Republic of Congo have escaped after a landing accident which destroyed the regional jet. The aircraft,

Commission Chairperson Welcomes the Doha Framework for a Comprehensive Peace Agreement between the Government of the Democratic Republic of Congo (DRC) and the AFC/M23

An AirJet Angola ERJ-145 left the runway during landing in Kolwezi, DRC. The aircraft burned after stopping in the dirt as all aboard reportedly evacuated safely.

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo (DRC).